A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract

• Status: Recruiting
• Trial end date: 2022-10-30
• Target enrollment: 0
• Participant gender: All

Summary

To assess the safety of Dextenza compared to an active control, prednisolone acetate suspension, for the treatment of postoperative pain and inflammation following ocular surgery for pediatric cataract.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ocular Therapeutix, Inc.
• Treatments: Prednisolone

Criteria

Inclusion Criteria:

• Pediatric cataract diagnosis

• Subject is >0 - 3 years of age

Exclusion Criteria:

• Any intraocular inflammation in the study eye

• Ocular hypertension or glaucoma

• Evidence of acute external ocular infections